Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 12 840 / https://doi.org/10.3332/ecancer.2018.840

Review

Are aggressive epithelial cancers ‘a disease’ of Eutherian mammals?

Placental immune editing switches (PIES) have not evolved to prevent or to cause cancer but to make feto-maternal immune tolerance possible, which is at the very core of our placental mammalian (‘Eutherian’) nature. Aggressive epithelial cancers might be an unfortunate ‘side effect’ of this highly sophisticated biological nature. Microenvironmental properties in the placenta and decidua are thought to be a key to feto-maternal immune tolerance. Recently, in 2016–2018, we published the first human genomic and epigenomic evidence of similar gene expression profiles in immune regulatory genes in cancer (primary lobular infiltrating breast cancer and ipsilateral axillary metastatic lymph nodes) and both placenta and decidua of the same young patient with breast carcinoma during pregnancy. These findings led us to speculate that ectopic expression, or repression, of ‘PIES’ might be used by cancer cells during carcinogenesis or cancer progression to elude immune vigilance in spite of tumour-associated antigens or evolving neo antigenic landscapes. Cancers are well known to frequently express embryonic antigens, such as carcinoembryonic antigen, used as cancer markers and detectable in the blood circulation, or to express ectopic hormones. Why should cancer cells invent de novo complex new immune suppression mechanisms, if they could simply use innate ones developed during the long-term evolution of placental mammals in order to hide fetal paternal antigens from the mother’s own immune system?

Monotremata (Prototheria-like Echidnas or Platypus Ornithoryncus) are nonplacental egg-laying mammals and, in spite of rudimentary breast epithelial ducts and lobules, they are seldom reported to suffer from aggressive breast cancers.

Keywords: cancer immune escape, cancer immune suppression, placental immune editing, cancer immunotherapies, immune vigilance concepts

Loading Article Metrics ... Please wait

Related articles

Review: Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis

Abstract | Full Article | PDF Published: 16 Aug 2018 / https://doi.org/10.3332/ecancer.2018.859

Case Report: Recurrent dermatofibrosarcoma protuberans: challenging a surgeon’s dexterity for the ‘tricky’ margins

Abstract | Full Article | PDF Published: 13 Aug 2018 / https://doi.org/10.3332/ecancer.2018.858

Policy: The understanding of healthcare workers on the content of palliative care policy in Shesilweni Swaziland: a qualitative study

Abstract | Full Article | PDF Published: 10 Aug 2018 / https://doi.org/10.3332/ecancer.2018.857

Case Report: Two cases of white globe appearance in non-cancerous stomach

Abstract | Full Article | PDF Published: 07 Aug 2018 / https://doi.org/10.3332/ecancer.2018.856

Research: Survival probabilities and trends for lip, oral cavity and oropharynx cancers in the Northern Region of Portugal in the period 2000–2009

Abstract | Full Article | PDF Published: 31 Jul 2018 / https://doi.org/10.3332/ecancer.2018.855



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation